Angioimmunoblastic T-Cell Lymphoma: Treatment Options

Angioimmunoblastic
T-Cell Lymphoma

Treatment Options

Patients with AITL may be treated with a steroid that can temporarily relieve the symptoms caused by the immune system’s reaction to the cancer cells, such as joint inflammation or pain and skin rash.

Recommended first-line therapy is either a clinical trial or a multiagent chemotherapy regimen, such as CHOP (cyclophosphamide doxorubicin, vincristine, and prednisone). Sometimes higher doses of chemotherapy followed by stem cell transplantation may be added to multiagent chemotherapy.

Several drugs have been tested in small clinical trials (alone or in combination with current chemotherapy regimens) and show promise for the treatment of AITL, including:

  • Brentuximab vedotin (Adcetris)
  • Lenalidomide (Revlimid)
  • Panobinostat (Farydak)

Learn More

To learn more about AITL, download the Angioimmunoblastic T-Cell Lymphoma Fact Sheet. Want to talk to someone? For answers to lymphoma-related questions 
and resources, contact our Helpline at (800) 500-9976 or helpline@lymphoma.org.

YouTube video

Additional Resources

To learn more about ATLL, download the Adult T-Cell Leukemia/Lymphoma Fact Sheet.

Events

Lymphoma Talk: Los Angeles

Westdrift Manhattan Beach 1400 Parkview Avenue, Manhattan Beach, California

Lymphoma Talk is a two-hour weekday evening in-person program led by lymphoma experts that provides […]